- Home
- BNTC vs CRGO Comparison
BNTC vs CRGO Comparison
Compare BNTC & CRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTC
- CRGO
- Stock Information
- Founded
- BNTC 1995
- CRGO 2012
- Country
- BNTC United States
- CRGO Israel
- Employees
- BNTC N/A
- CRGO N/A
- Industry
- BNTC Biotechnology: Pharmaceutical Preparations
- CRGO Blank Checks
- Sector
- BNTC Health Care
- CRGO Finance
- Exchange
- BNTC Nasdaq
- CRGO Nasdaq
- Market Cap
- BNTC 88.1M
- CRGO 73.8M
- IPO Year
- BNTC N/A
- CRGO N/A
- Fundamental
- Price
- BNTC $10.68
- CRGO $2.24
- Analyst Decision
- BNTC Strong Buy
- CRGO Strong Buy
- Analyst Count
- BNTC 5
- CRGO 2
- Target Price
- BNTC $22.60
- CRGO $4.75
- AVG Volume (30 Days)
- BNTC 33.8K
- CRGO 170.5K
- Earning Date
- BNTC 11-14-2024
- CRGO 11-25-2024
- Dividend Yield
- BNTC N/A
- CRGO N/A
- EPS Growth
- BNTC N/A
- CRGO N/A
- EPS
- BNTC N/A
- CRGO N/A
- Revenue
- BNTC N/A
- CRGO $21,378,000.00
- Revenue This Year
- BNTC N/A
- CRGO $18.44
- Revenue Next Year
- BNTC N/A
- CRGO $30.14
- P/E Ratio
- BNTC N/A
- CRGO N/A
- Revenue Growth
- BNTC N/A
- CRGO 9.90
- 52 Week Low
- BNTC $2.69
- CRGO $1.27
- 52 Week High
- BNTC $12.89
- CRGO $3.62
- Technical
- Relative Strength Index (RSI)
- BNTC 53.25
- CRGO 66.39
- Support Level
- BNTC $10.25
- CRGO $2.01
- Resistance Level
- BNTC $10.89
- CRGO $2.77
- Average True Range (ATR)
- BNTC 0.43
- CRGO 0.23
- MACD
- BNTC -0.07
- CRGO 0.09
- Stochastic Oscillator
- BNTC 69.39
- CRGO 64.67
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV). BB-301 is currently under development by the group; it is designed to slow, or halt, the disease progression.
About CRGO Freightos Limited Ordinary shares
Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters. forwarders, and dozens of airlines and ocean carriers. WebCargo by Freightos is a freight platform connecting carriers and forwarders in particular an air cargo eBooking platform. Freightos.com is a digital international freight marketplace for importers and exporters for instant pricing, booking, and shipment management. The company operates in two segments-Platform segment and Solutions segment. Geographically, the company operates in Europe, Hong Kong, United States which is majority revenue generator and others.